دورية أكاديمية

BILATERAL UVEAL METASTASES SECONDARY TO PROSTATE ADENOCARCINOMA.

التفاصيل البيبلوغرافية
العنوان: BILATERAL UVEAL METASTASES SECONDARY TO PROSTATE ADENOCARCINOMA.
المؤلفون: Cochran KJ; School of Medicine, Tufts University, Boston, Massachusetts., Gray JR; Tennessee Oncology, Nashville, Tennessee; and., Meluch AA; Tennessee Oncology, Nashville, Tennessee; and., Reichstein DA; Tennessee Retina, Nashville, Tennessee.
المصدر: Retinal cases & brief reports [Retin Cases Brief Rep] 2020 Summer; Vol. 14 (3), pp. 260-264.
نوع المنشور: Case Reports; Journal Article
اللغة: English
بيانات الدورية: Publisher: Wolters Kluwer Health Country of Publication: United States NLM ID: 101298744 Publication Model: Print Cited Medium: Internet ISSN: 1937-1578 (Electronic) Linking ISSN: 19351089 NLM ISO Abbreviation: Retin Cases Brief Rep Subsets: MEDLINE
أسماء مطبوعة: Original Publication: Hagerstown, MD : Wolters Kluwer Health, c2007-
مواضيع طبية MeSH: Adenocarcinoma/*secondary , Prostatic Neoplasms/*diagnosis , Uvea/*diagnostic imaging , Uveal Neoplasms/*secondary, Adenocarcinoma/diagnosis ; Aged ; Biopsy ; Humans ; Male ; Neoplasm Metastasis ; Ultrasonography ; Uveal Neoplasms/diagnosis
مستخلص: Purpose: To report a patient with bilateral uveal metastases secondary to previously quiescent prostate adenocarcinoma with a 22-month follow-up.
Methods: Retrospective chart review was performed for this patient.
Results: Androgen deprivation therapy and external beam radiation therapy were shown to manage ocular symptoms in a sixty-nine-year-old man previously diagnosed with adenocarcinoma of the prostate.
Conclusion: Uveal metastases can be the first site of systemic metastasis even long after initial diagnosis and treatment of prostate adenocarcinoma; the 17 years between this patient's treatment for adenocarcinoma and commencement of his ocular symptoms is the longest interval reported. Hormonal therapy, in conjunction with radiation therapy, can successfully reduce tumor burden in these patients and improve visual symptoms over time.
References: Frota AC, Bakalian S, Gregoire FJ, et al. Pseudomelanoma in a patient with prostate adenocarcinoma. Can J Ophthalmol 2007;42:305–306.
Saadi A, Kerkeni W, Bouzouita A, et al. Bilateral orbital metastasis of prostatic adenocarcinoma. Images Clin Urol 2016;94:e3–e4.
Dieckert JP, Berger BB. Prostatic carcinoma metastatic to choroid. Br J Ophthalmol 1982;66:234–239.
Martin V, Cuenca X, Lopez S, et al. Iris metastasis from prostate carcinoma: a case report and review of the literature. Cancer Radiother 2015;19:331–333.
Albadainah F, Khader J, Salah S, Salem A. Choroidal metastasis secondary to prostatic adenocarcinoma: case report and review of literature. Hematol Oncol Stem Cell Ther 2015;8:34–37.
Obek C, Kural AR, Yaycioglu O, et al. Metastatic adenocarcinoma of the prostate to the uvea as the initial presenting symptom in a 49-year-old man. Urology 2001;58:106.
Barbón JJ, Gonzalez-Tuero J, Gay LL, et al. Regression of a choroidal metastasis from prostate adenocarcinoma after hormonal therapy. Arch Soc Esp Oftalmol 2007;82:715–718.
Ermoian RP, Kalina RE, Yu EY, Parvathaneni U. Ocular prostate cancer metastasis treated with external beam radiation. Retin Cases Brief Rep 2011;5:306–308.
Kancherla S, Bianciotto CG, Shields CL. Case reports in ocular oncology: prostate carcinoma, a common cancer in men, rarely metastasizes to the eye. Retina Today 2011;52–54.
Shields CL, Shields JA, Gross NE, et al. Survey of 520 eyes with uveal metastases. Ophthalmology 1997;104:1265–1276.
تواريخ الأحداث: Date Created: 20171209 Date Completed: 20210421 Latest Revision: 20210421
رمز التحديث: 20221213
DOI: 10.1097/ICB.0000000000000689
PMID: 29219931
قاعدة البيانات: MEDLINE
الوصف
تدمد:1937-1578
DOI:10.1097/ICB.0000000000000689